| Management Update | |
| | |
|
EMED Mining Public Limited (AIM: EMED, TSX: EMD), the Europe-based minerals development and exploration company, announces that Mr. John Leach, the Company's Chief Financial Officer will leave the Company following the AGM on 29 July 2015 one month before the end of his agreed contract term.
Having successfully completed the £64.9 million financing package which ensures that the Company is fully funded to commence and expand production to 7.5Mtpa, Mr. Leach has decided to focus on new opportunities.
EMED's finance function will be overseen by David Carrasco, CFO of EMED Tartessus, and George Hadjineophytou, Group Financial Controller on an interim basis while the Board considers all replacement options.
Alberto Lavandeira, CEO of the Company, commented: "I would like to thank John for all his help. He was instrumental in ensuring that the Company always had sufficient funding in place and has been a valued member of the Company since it came to the market. We wish him well in his future endeavours."
EMED Roger Davey/Alberto Lavandeira +34 959 59 28 50
Canaccord Genuity Limited (Corporate Broking) Henry Fitzgerald-O'Connor/Oliver Donaldson +44 207 523 8000
Brandon Hill Capital Oliver Stansfield +44 203 463 5061
Walbrook PR Nick Rome +44 207 933 8783
|
|
|
EMED Mining Public Ltd
|
|
DEVELOPMENT STAGE |
CODE : EMED.L |
ISIN : CY0000100319 |
|
| |
ProfileMarket IndicatorsVALUE : Projects & res.Press releasesAnnual reportRISK : Asset profileContact Cpy |
EMED is a gold and copper development stage company based in Cyprus. EMED develops gold, copper and zinc in Cyprus and in Spain, and holds various exploration projects in Cyprus. Its main assets in development are PROYECTO RIO TINTO in Spain and KLIROU in Cyprus and its main exploration properties are DETVA, STIAVNICA-HODRUSA and BIELY VRCH in Slovakia and KLIROU in Cyprus. EMED is listed in United Kingdom. Its market capitalisation is GBX 54.7 billions as of today (US$ 65.5 billions, € 57.4 billions). Its stock quote reached its lowest recent point on September 18, 2015 at GBX 0.12, and its highest recent level on January 17, 2022 at GBX 404.00. EMED has 135 475 650 shares outstanding. |